Search - tctmd.com

Displaying 581 - 600 of 1740

Sort: Relevancy | Date

News Daily News

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

L.A. McKeown

December 01, 2016

News Daily News

Beta-blocker Therapy Seems to Boost Post-PCI Outcomes in Patients With ACS

Todd Neale

November 22, 2016

News Conference News AHA 2016

全国数据认为 PCI 在没有外科手术后备支援的中心“可能实施”

Yael L. Maxwell

November 16, 2016

News Conference News AHA 2016

Según Datos a Nivel Nacional, las PCI realizadas en Centros Sin Soporte Quirúrgico ‘Probablemente No Tengan Problemas’

Yael L. Maxwell

November 16, 2016

News Conference News AHA 2016

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

Yael L. Maxwell

November 16, 2016

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Daily News

登记表数据显示原发性 PCI 患者比伐卢定与肝素使用率波动

Yael L. Maxwell

November 11, 2016

News Daily News

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

November 11, 2016

News Daily News

Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias

Yael L. Maxwell

November 11, 2016

Presentation Cardiovascular Interventions 2016

Physiology As Essential Skill - How to be an expert: Caveats, Shortcuts

Presenter: Nils P. Johnson

November 09, 2016

Presentation Cardiovascular Interventions 2016

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

Presenter: James Hermiller

November 08, 2016

News Conference News TCT 2016

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Yael L. Maxwell

November 01, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

ILUMIEN 3: OCT Imaging Matches IVUS but Fails To Beat Angiography for Stent Guidance in PCI

News Conference News TCT 2016

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

Shelley Wood

October 30, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

News Daily News

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

L.A. McKeown

October 05, 2016

News Daily News

比伐卢定和普通肝素对有无 ST 段抬高的 ACS 患者没有任何差异：MATRIX

Shelley Wood

October 03, 2016

Advertisement

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

Beta-blocker Therapy Seems to Boost Post-PCI Outcomes in Patients With ACS

全国数据认为 PCI 在没有外科手术后备支援的中心“可能实施”

Según Datos a Nivel Nacional, las PCI realizadas en Centros Sin Soporte Quirúrgico ‘Probablemente No Tengan Problemas’

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

登记表数据显示原发性 PCI 患者比伐卢定与肝素使用率波动

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias

Physiology As Essential Skill - How to be an expert: Caveats, Shortcuts

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

比伐卢定和普通肝素对有无 ST 段抬高的 ACS 患者没有任何差异：MATRIX

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content